Surmodics, Inc.
9924 West 74th Street
Eden Prarie
Minnesota
55344-3523
United States
Tel: 952-829-2700
Fax: 952-829-2743
Website: http://www.surmodics.com/
Email: info@surmodics.com
338 articles about Surmodics, Inc.
-
Surmodics Reports Third Quarter Fiscal 2022 Results
7/27/2022
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2022 third quarter ended June 30, 2022 and updated its financial outlook for its fiscal 2022.
-
Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27
7/19/2022
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2022 conference call on Wednesday, July 27, at 7:30 a.m. CT (8:30 a.m. ET).
-
Surmodics Reports Second Quarter Fiscal 2022 Results
4/27/2022
Surmodics, Inc. today announced results for its fiscal 2022 second quarter ended March 31, 2022 and updated its financial outlook for its fiscal 2022.
-
Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases
4/27/2022
Surmodics, Inc. (NASDAQ : SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that its Pounce™ Thrombectomy System achieved 100 percent technical success in 20 First-in-Human (FIH) procedures.
-
Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
4/25/2022
Surmodics, Inc. announced today that Gary Ansel, MD, will present First-In-Human (FIH) data on the company’s Pounce™ Thrombectomy System on Tuesday, April 26, at the Charing Cross International Symposium in London.
-
Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27
4/19/2022
Surmodics, Inc. today announced that it will host a live webcast of its second quarter fiscal 2022 conference call on Wednesday, April 27, at 7:30 a.m. CT (8:30 a.m. ET).
-
Surmodics Inc. to Host Virtual Annual Meeting of Shareholders
2/4/2022
Surmodics, Inc. will hold its Annual Meeting of Shareholders on Thursday, February 10, at 4:00 p.m. CT (5:00 p.m. ET), as a virtual meeting.
-
Surmodics Reports First Quarter Fiscal 2022 Results
2/3/2022
Surmodics, Inc. today announced results for its fiscal 2022 first quarter ended December 31, 2021.
-
Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3
1/26/2022
Surmodics, Inc. today announced that it will host a live webcast of its first quarter fiscal 2022 conference call on Thursday, February 3, at 7:30 a.m. CT (8:30 a.m. ET).
-
Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance
11/10/2021
Surmodics, Inc. today announced results for its fiscal 2021 fourth quarter ended September 30, 2021 and provided its financial outlook for its fiscal 2022.
-
Surmodics to Webcast Fourth Quarter Fiscal 2021 Earnings Conference Call on November 10
11/2/2021
Surmodics, Inc. today announced that it will host a live webcast of its fourth quarter fiscal 2021 conference call on Wednesday, November 10, at 7:30 a.m. CT (8:30 a.m. ET).
-
Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter
9/29/2021
Surmodics, Inc. today announced the successful first clinical uses of of the Sublime™ Radial Access .018 RX PTA Dilatation Catheter.
-
Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
8/4/2021
Surmodics, Inc. , today announced results for its fiscal 2021 third quarter ended June 30, 2021 and updated its financial outlook for its fiscal 2021.
-
Surmodics Announces Successful First Patient Use of Pounce™ Thrombectomy System
7/29/2021
Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that J. Michael Bacharach, MD, vascular interventionalist/cardiologist at North Central Heart, a division of Avera Heart Hospital in Sioux Falls, South Dakota, successfully treated the first patient with the company’s Pounce™ Thrombectomy System.
-
Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited
7/6/2021
Surmodics announced today that it has acquired privately held Vetex Medical Limited.
-
Surmodics Reports Second Quarter Fiscal 2021 Results and Issues Fiscal 2021 Revenue and EPS Guidance
4/28/2021
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2021 second quarter ended March 31, 2021 and provided its financial outlook for its fiscal 2021.
-
Surmodics to Webcast Second Quarter Fiscal 2021 Earnings Conference Call on April 28
4/20/2021
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2021 conference call on Wednesday, April 28, at 7:30 a.m. CT (8:30 a.m. ET).
-
Surmodics Announces Successful First Patient Uses of Two Sublime™ Radial Access Platform Devices
4/1/2021
Sublime™ Radial Access .014 RX PTA Dilatation Catheter, Sublime Radial Access Guide Sheath Deliver Outstanding Performance in Initial Physician Evaluations
-
Surmodics to Present at Sidoti & Company Virtual Investor Conference
3/17/2021
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Tim Arens, senior vice president of finance and chief financial officer, will make a presentation at the Sidoti & Company Virtual Investor Conference
-
Surmodics Reports First Quarter Fiscal 2021 Results
2/9/2021
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2021 first quarter ended December 31, 2020. Summary of First Quarter and Recent Highlights Revenue of $22.3 million, a decrease of 1% year-over-year